Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C23- Malignant neoplasm of gallbladder Health Condition 3: C321- Malignant neoplasm of supraglottis Health Condition 4: B956- Staphylococcus aureus as the causeof diseases classified elsewhere
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Siddarth K C
Eligibility
Inclusion criteria
Inclusion criteria: 1 Adult more than 18 years 2 Admitted in ICU or HDU 3 Diagnosed with Cancer 4 Whose Sample is sent for culture in microbiology Lab 5 Labortaory Confirmed, recognized pathogen and opportunistic commensal
Exclusion criteria
Exclusion criteria: 1 Pregnant individual and paediatric patient 2 Laboratory culture conatmination 3 who are not willing to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the incidence of Multi Drug Resistant infection in crtically ill patient admitted in ICU and HDU in tertiary oncology CentreTimepoint: 8 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To determine the incidence of Multi Drug Resistant Hospital acquired infection in crtically ill patient admitted in ICU 2 To identify associated risk factors in MDR infection 3 Comparision of mortality rates hospital stay duration & complications Timepoint: 8 Weeks | — |
Countries
India
Contacts
Public ContactVijeta Bajpai Batra
HBCH and Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Centre), Varanasi
Outcome results
None listed